CTGCT Science Talks April - Dr. Thomas Fox - CTGCT On Monday, 13th of April 2026, 2:00 PM (Ljubljana/Berlin time),Dr. Thomas Fox, from the Dana-Farber Cancer Institute & Boston Children’s Hospital, Harvard Medical School and UCL Institute of Immunity ...

⏰ Don't miss the next #CTGCT #ScienceTalks with Dr. Thomas Fox! Explore the future of Programmable T Cell Therapies:

📅 Monday, April 13, 2026 🕒 2:00 PM
ctgct.si/en/objave/ct...

#Biotech #TCell #CRISPR

How AI is Helping Us Design the Proteins of the Future - CTGCT Imagine if we could design the "building blocks" of life just like we design a new house or a car. Instead of relying on what nature has given us through millions of years of evolution, what if we cou...

Can AI design the proteins of the future?

In our latest #CTGCT #ScienceTalks, Dr. @ajasjaljubetic.bsky.social showcased how AI is building proteins from scratch, from stable vaccines to microscopic nanorobots.

Check out the breakdown and watch the recording: ctgct.si/en/objave/ai...

Join us on our next #CTGCT #ScienceTalks with Dr. @Thomas Fox ( @harvardmed.bsky.social / @ucl.ac.uk ) for an exciting talk on "Programmable T Cell Therapies: From Precision Genome Editing to In Vivo Programming"

📅April 13, 2026 | 2:00 PM (CET)
ctgct.si/en/objave/ct...

CTGCT at the 12th National Rare Disease Day Conference - CTGCT On Friday, February 27, 2026, part of our team joined experts, decision-makers, and patient advocates at the 12th National Rare Disease Day Conference held at the Congress Center Brdo pri Kranju.The e...

The #CTGCT team joined the 12th National Rare Disease Day Conference.
Highlights:
✅ #Urbagen: 1st Slovenian rare disease drug milestone
✅ @genehproject.bsky.social : Proud partners in patient-centric research
✅ Bridging the gap from lab to bedside
ctgct.si/en/objave/12...
#RareDiseaseDay #Slovenia

Job Openings - CTGCT The work at the Centre for the Technologies of Gene and Cell Therapy is focused on translating research into treatments through innovative strategies, including advanced gene editing, cell-based treat...

New positions alert! We are #hiring at the #CTGCT. Don't miss this chance to join our team
ctgct.si/en/jobs/

CTGCT Science Talks March - Dr. Ajasja Ljubetič - CTGCT On Monday, 2nd of March 2026, 2:00 PM (Ljubljana/Berlin time),Dr. Ajasja Ljubetič, Research Assistant Processor and group leader in the Department of Synthetic Biology and Immunology at the National I...

Join us on the #CTGCT #Science_Talks #webinar

We’re pleased to host Dr.@ajasjaljubetic.bsky.social from Dept. Syn. Bio and Immuno. at the @kemijski.bsky.social . He will present his work titled “Overview of de novo protein design (and design of novel binders)”.

ctgct.si/en/objave/ct...

Job Openings - CTGCT The work at the Centre for the Technologies of Gene and Cell Therapy is focused on translating research into treatments through innovative strategies, including advanced gene editing, cell-based treat...

New year, new teammates at #CTGCT! 🥼

We are hiring 5 key roles at @kemijski.bsky.social:

🧬 2x GMP Experts: PhD + 4yrs exp. in bioprocess/QA.
🔬 3x Postdoc Researchers: PhD + 3yrs postdoc exp. preferred.

📅 Deadline: Feb 19, 2026
Details: ctgct.si/en/jobs/

#Hiring #GeneTherapy

CTGCT Science Talks February - Dr. Shady Sayed - CTGCT On Monday, 2nd of February 2026, 2:00 PM (Ljubljana/Berlin time), Dr. Shady Sayed from the Department of Medical Systems Biology, Faculty of Medicine Carl Gustav Carus, TU Dresden, Dresden, GermanyFil...

Join us on the #CTGCT #Science_Talks #webinar

We’re pleased to host Dr. Shady El-Husseiny,TU Dresden. He will present his work titled “Application of CRISPR base editors in innovative cancer therapies”.

ctgct.si/en/objave/ct...

Boosting Immunity After Transplantation: The Future of Automated T-Cell Therapy - CTGCT For patients undergoing a life-saving organ transplant, the road to recovery is often a delicate balancing act. While the new organ offers a second chance, the drugs needed to prevent the body from re...

Can automation revolutionize viral defense after transplant? 🧬
At #CTGCT #ScienceTalks, Claudia Beltran Mestres from Charité Berlin shared how automated G-Rex bioreactors produce "fitter" T-cells to fight viral infections after a transplant.

Article: ctgct.si/en/objave/bo...

Ceremonial Signing of the Agreement on Co-Financing of the CTGCT - CTGCT We are proud to announce a historic milestone for our project. On December 22, 2025, the Minister of Higher Education, Science, and Innovation, Dr. Igor Papič, and the Director of the National Institu...

🚀 Big news!

The #CTGCT co-financing agreement is signed. This €30M joint investment (EU + Slovenia) will help translating knowledge into clinical practice.

Led by Dr. Mojca Benčina, we’re: 🔬 Advancing therapies 🥼 Bringing talent home 🤝 Partnering globally

Full story: ctgct.si/en/objave/ce...

CTGCT Newsletter No. 3 - Happy Holidays to everyone! - CTGCT As the year wraps up, we want to share our third official CTGCT newsletter, summarizing a period of great growth, both in our team size and our scientific impact!In the last six months, we have experi...

#CTGCT #Newsletter No. 3 is out!
From making space for our new facility to hosting our CTGCT Days, it’s been a massive year.

Catch up on:
Team expansion
#CTGCTDays2025 highlights
Latest open-access research
Plans for 2026 and more

ctgct.si/en/objave/ct...

CTGCT Science Talks January - Claudia Beltran Mestre - CTGCT On the 12th of January 2026, Claudia Beltran Mestre, from the Berlin Center for Advanced Therapies at Charité Universitätsmedizin Berlin will present in our CTGCT Science Talks webinar series. The tal...

Join us on 12 Jan 2026 at 14:00 (CET) for our next #CTGCT #ScienceTalks #webinar with Claudia Beltran Mestres from BeCAT at Charité Berlin on “Automation of Antiviral T cell Product Manufacturing”

🔗 Register now and get the link on the day of the event!

ctgct.si/en/objave/ct...

Bridging the Gap: The Role of GMP Simulation in ATMP Translation - CTGCT In recent decades, the medical toolbox has expanded dramatically. While traditional medicine relied on synthetic drugs (small molecules interacting with specific pathways) and later biologicals like a...

Simulation is the secret sauce for "Living Drugs"!

Aiko Ballardini from @umcutrecht.bsky.social explains how using a GMP Simulation facility helps researchers quickly transform lab ideas into safe, compliant #ATMPs for patients.

Link: ctgct.si/en/objave/br...

#Biotech #GMP #CTGCT #ScienceTalks

Job Openings - CTGCT The work at the Centre for the Technologies of Gene and Cell Therapy is focused on translating research into treatments through innovative strategies, including advanced gene editing, cell-based treat...

#QC ASSISTANT #JOB_ALERT!
The #CTGCT as part of the @kemijski.bsky.social is hiring! Help us build the future of Gene & Cell Therapy by ensuring our quality system meets #GMP/cGxP standards.

Req: Master's Degree & #QC/QA experience (preferred).

Deadline: Nov 25, 2025
Learn more: ctgct.si/en/jobs/

Job Openings - CTGCT The work at the Centre for the Technologies of Gene and Cell Therapy is focused on translating research into treatments through innovative strategies, including advanced gene editing, cell-based treat...

📢 JOB ALERT: #CTGCT as part of @kemijski.bsky.social is expanding! 🧬

We're #hiring for 3 roles:

#Independent #Researcher (PI) (Deadline: Nov 23)

#GMP #Expert (Deadline: Nov 20)

#GMP #Assistant (Deadline: Nov 20)

Check all the details in this link: ctgct.si/en/jobs

CTGCT Highlights Role of AI in Medicine at Austria-Slovenia Business Forum - CTGCT On October 23, 2025, the "Austria – Slovenia: Connected for the Future" business forum happened in Vienna, uniting nearly 300 leaders from the economy, research, and diplomacy. The event, organized by...

#CTGCT was in Vienna! Our Project Manager Vesna Merc participated in a roundtable at the Austria-Slovenia Business Forum organised by SPIRIT Slovenia.

Read the full recap on our blog! 👇 ctgct.si/en/objave/ct...

#AIinMedicine #HealthTech #Innovation #SloveniaAustria

Next #CTGCT #ScienceTalks - Dr. Andrea Rayat, Associate Professor in Bioseparations and Downstream Processing at University College London

📅 Date: Monday, 3rd of November
🕒 Time: 2:30 Ljubljana/Berlin time
🖊 Register now!

Register here: forms.office.com/e/KJTTsMyETk
#Webinar

A Nobel-Worthy Topic: Harnessing Inflammation to Fight Cancer - CTGCT On October 6th, the very day the 2025 Nobel Prize in Physiology or Medicine was awarded for groundbreaking work in T-cell based cancer immunotherapy, our CTGCT community had the pleasure of hosting a ...

This led her team to ask a transformative question: could this powerful inflammatory potential be repurposed to treat cancer?

To find out, check the recording of the webinar

ctgct.si/en/objave/ha...

#CTGCT #ScienceTalks

From Film Editing to RNA Editing: How RNA Trans-splicing Could Treat CTNNB1 Syndrome - CTGCT Imagine you're in a movie editing studio, trying to fix a film with some corrupted scenes. The film is vital, as it plays a crucial role in the development and function of an entire movie franchise. S...

Read the full blog for the metaphor, methods, and implications: ctgct.si/en/objave/fi...

Comments and questions welcome. Specially on potential paths to in vivo testing and clinical translation.

@rjerala.bsky.social #CTGCT

#CTGCT Science Talks are back!

This time we have a talk open to everyone by dr. Iva Hafner Bratkovič from the Department of Synthetic Biology and Immunology at the @kemijski.bsky.social.
Her talk is titled "Inflammasome-inspired cancer immunotherapy"

Join us! forms.office.com/e/KJTTsMyETk
#Webinar

#Kemomed, d.o.o. (Slovenia) is bringing solutions for all current and future research questions that researchers and people working in laboratories might have. They help you reach your goals easier and faster.

Kemomed is a Coffee Break #sponsor for the #CTGCTDays2025
#CTGCT
#GCT
#Conference

On Wednesday the 17th they have brought a representative from Thermo Fisher to present more about the product they have available in Slovenia.

Get a chance to meet their representatives in Slovenia while discussing your needs for biopharma research and development.

#CTGCT #GCT #Conference

Join us during the events and get a chance to meet their representatives in Slovenia while discussing your needs for biopharma research and development.

#CTGCT #GCT #Conference

#Mikro+Polo is the best specialized supplier in Slovenia of laboratory, medical, and processing equipment, as well as accessories, chemicals and laboratory furniture.

Mikro+Polo is a Coffee Break #sponsor for the #CTGCTDays2025. Join us!

#CTGCT #GCT #Conference

Help us learn more about the barriers and opportunities that industry and academia faces when working towards a #GeneTherapy

#CTGCT #RareDiseases

10 more days to apply for this position!

#hiring #GeneAndCellTherapy #CTGCT

Just letting you know...
#CTGCT Days 2025

Just 1 week left to take advantage of our Early Bird Registration to the #CTGCT Days 2025.

Don't miss this opportunity to attend 2 events, 2 round tables, and workshops by accela.eu for only 100€ in beautiful Ljubljana.

#Conference #GCT

Job Openings - CTGCT The work at the Centre for the Technologies of Gene and Cell Therapy is focused on translating research into treatments through innovative strategies, including advanced gene editing, cell-based treat...

The #CTGCT is looking for a Technician/Caretaker for the Animal Laboratory. Check the description of the position and submit your CV if you would like to join our team

⚠Candidates should submit their applications by August 17th❗

ctgct.si/en/jobs/

#HiringAlert

CTIS public portal - a great tool for finding and exploring clinical trials in Europe - CTGCT The Clinical Trials Information System (CTIS) public portal is a new European tool that allows anyone to access information about clinical trials taking place in the European Union (EU) and European E...

🔬 New blog post: CTIS Public Portal – your gateway to 7,752+ clinical trials across Europe

Perfect for patients, researchers & anyone curious about medical innovation in Europe.

#ClinicalTrials #MedicalResearch #PatientAdvocacy #CTGCT

ctgct.si/en/objave/ct...